Publications by authors named "Taro Funakoshi"

Claim this Profile
P
Population pharmacokinetic analysis of bevacizumab in Japanese cancer patients with proteinuria: a prospective cohort study.
Takashi Masuda, Taro Funakoshi, Takahiro Horimatsu, Sho Masui, Daiki Hira

Cancer Chemother Pharmacol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer diagnosis and prognosis after initiation of hemodialysis: multicenter Japan CANcer and DialYsis (J-CANDY) study.
Naoya Toriu, Shinya Yamamoto, Takeshi Matsubara, Yuki Kataoka, Kaoru Sakai, Taro Funakoshi

Clin Kidney J· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world outcomes of FOLFOXIRI plus bevacizumab in patients with metastatic colorectal cancer: the JSCCR-TRIPON study.
Yoshiyuki Yamamoto, Hiroki Yukami, Tatsuro Yamaguchi, Hisatsugu Ohori, Sachiko Nagasu, Taro Funakoshi

Int J Clin Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low serum concentrations of bevacizumab and nivolumab owing to excessive urinary loss in patients with proteinuria: a case series.
Takashi Masuda, Taro Funakoshi, Takahiro Horimatsu, Shinya Yamamoto, Takeshi Matsubara

Cancer Chemother Pharmacol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Magnesium Supplementation in Cancer Patients Developing Hypomagnesemia Due to Anti-EGFR Antibody: A Systematic Review.
Taigo Kato, Takahisa Kawaguchi, Taro Funakoshi, Yutaka Fujiwara, Yoshinari Yasuda

Cancer Diagn Progn· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteinuria frequency and subsequent renal dysfunction in bevacizumab-treated patients: a single center, retrospective, observational study.
Shigeki Kataoka, Yoshitaka Nishikawa, Taro Funakoshi, Takahiro Horimatsu, Minoru Sakuragi

Int J Clin Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Removal rate of 5-fluorouracil and its metabolites in patients on hemodialysis: a report of two cases of colorectal cancer patients with end-stage renal failure.
Hirotaka Imamaki, Mitsuaki Oura, Fumiya Oguro, Yoshitaka Nishikawa, Shunsaku Nakagawa, Taro Funakoshi

Cancer Chemother Pharmacol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medical care costs according to the stage and subtype of breast cancer in a municipal setting: a case study of Hachioji City, Japan.
Yoshitaka Nishikawa, Nobukazu Agatsuma, Takahiro Utsumi, Taro Funakoshi, Yukiko Mori

Breast Cancer· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of Cabozantinib to Treat MET -amplified Pediatric Colorectal Cancer.
Sadahiro Fukui, Katsutsugu Umeda, Hirohito Kubota, Atsushi Iwai, Ryo Akazawa, Taro Funakoshi

J Pediatr Hematol Oncol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between homologous recombination gene variants and efficacy of oxaliplatin-based chemotherapy in advanced pancreatic cancer: prospective multicenter observational study.
Tomohiro Kondo, Masashi Kanai, Junichi Matsubara, Daisuke Yamaguchi, Takashi Ura, Taro Funakoshi

Med Oncol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Severe Renal Dysfunction on the Plasma Levels of DNA-Reactive Platinum after Oxaliplatin Administration.
Shunsaku Nakagawa, Aimi Shimazaki, Taro Funakoshi, Atsushi Yonezawa, Shigeki Kataoka

Biol Pharm Bull· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decision making for anti-VEGF inhibitor continuation: dip stick? or urine protein/creatinine ratio? (VERSiON UP study).
Michio Nakamura, Taro Funakoshi, Shigeki Kataoka, Takahiro Horimatsu, Yoshitaka Nishikawa

BMC Cancer· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Indolent feature of Helicobacter pylori-uninfected intramucosal signet ring cell carcinomas with CDH1 mutations.
Mitsuhiro Nikaido, Nobuyuki Kakiuchi, Shin'ichi Miyamoto, Tomonori Hirano, Yasuhide Takeuchi, Taro Funakoshi

Gastric Cancer· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective evaluation and refinement of an S-1 dosage formula based on renal function for clinical application.
Masashi Takeuchi, Chiyo K Imamura, Eisuke Booka, Hiroya Takeuchi, Takuro Mizukami, Taro Funakoshi

Cancer Sci· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive genomic profiling for patients with chemotherapy-naïve advanced cancer.
Tomohiro Kondo, Junichi Matsubara, Pham Nguyen Quy, Keita Fukuyama, Motoo Nomura, Taro Funakoshi

Cancer Sci· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Successful management of hyperammonemia with hemodialysis on day 2 during 5‑fluorouracil treatment in a patient with gastric cancer: a case report with 5‑fluorouracil metabolite analyses.
Yoshinao Ozaki, Hirotaka Imamaki, Aki Ikeda, Mitsuaki Oura, Shunsaku Nakagawa, Taro Funakoshi

Cancer Chemother Pharmacol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful management of hyperammonemia with hemodialysis on day 2 during 5-fluorouracil treatment in a patient with gastric cancer: a case report with 5-fluorouracil metabolite analyses.
Yoshinao Ozaki, Hirotaka Imamaki, Aki Ikeda, Mitsuaki Oura, Shunsaku Nakagawa, Taro Funakoshi

Cancer Chemother Pharmacol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapy for patients with unresectable or metastatic small bowel adenocarcinoma: a systematic review.
Yoshitaka Nishikawa, Nobuaki Hoshino, Takahiro Horimatsu, Taro Funakoshi, Koya Hida

Int J Clin Oncol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term survival and renal dysfunction in a patient with recurrent colorectal cancer treated with Bevacizumab.
Shigeki Kataoka, Yoshitaka Nishikawa, Taro Funakoshi, Takahiro Horimatsu, Naoya Kondo

Clin J Gastroenterol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic analysis of a case of Helicobacter pylori-uninfected intramucosal gastric cancer in a family with hereditary diffuse gastric cancer.
Taro Funakoshi, Shin'ichi Miyamoto, Nobuyuki Kakiuchi, Mitsuhiro Nikaido, Takeshi Setoyama

Gastric Cancer· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[I. Chemotherapy for Small Bowel Adenocarcinoma].
Takahiro Horimatsu, Taro Funakoshi, Manabu Muto

Gan To Kagaku Ryoho· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapy in cancer patients undergoing haemodialysis: a nationwide study in Japan.
Taro Funakoshi, Takahiro Horimatsu, Michio Nakamura, Koichi Shiroshita, Koichi Suyama

ESMO Open· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accumulation of alpha-fluoro-beta-alanine and fluoro mono acetate in a patient with 5-fluorouracil-associated hyperammonemia.
Yoshitaka Nishikawa, Taro Funakoshi, Takahiro Horimatsu, Shin'ichi Miyamoto, Takeshi Matsubara

Cancer Chemother Pharmacol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paraneoplastic Limbic Encephalitis in a Human Epidermal Growth Factor Receptor-2-positive Gastric Cancer Patient Treated with Trastuzumab-combined Chemotherapy: A Case Report and Literature Review.
Yu Uneno, Akira Yokoyama, Yoshitaka Nishikawa, Taro Funakoshi, Yoshinao Ozaki

Intern Med· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapy for primary mediastinal yolk sac tumor in a patient undergoing chronic hemodialysis: a case report.
Haruki Hirakawa, Chiho Nakashima, Tomomi Nakamura, Masanori Masuda, Taro Funakoshi

J Med Case Rep· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis